Alhassan, N.
Trepanier, M.
Sabapathy, C.
Chaudhury, P.
Liberman, A. S.
Charlebois, P.
Stein, B. L.
Lee, L.
Article History
Received: 12 June 2018
Accepted: 12 December 2018
First Online: 19 December 2018
Compliance with ethical standards
:
: Dr. Liberman is on the medical advisory committee on ERAS for Merck, and on the advisory committee meeting for Novadaq. Dr. Lee is the recipient of an unrestricted educational grant from Johnson & Johnson. Drs. Alhassan, Trepanier, Sabapathy, Chaudhury, Charlebois, and Stein have no conflicts of interest or financial ties to disclose.
: The study protocol was approved by the local institutional review board.
: The need for informed consent was waived due to the retrospective nature of the study.